Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
Katherine McDermott, PhD
CONTACT
Katherine McDermott, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06870162
The investigators aim to conduct an open pilot trial to determine the initial feasibility of a self-directed writing-based intervention in individuals with chronic musculoskeletal pain and elevated pain catastrophizing. The investigators will assess the feasibility of recruitment, acceptability of the treatment, credibility and participant satisfaction, treatment adherence, and feasibility of assessments following pre-specified benchmarks.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Katherine McDermott, PhD
CONTACT
Katherine McDermott, PhD
PRINCIPAL_INVESTIGATOR
Mind-body interventions are some of the most effective treatments for chronic pain, yet due to lack of resources, many are inaccessible to the patients who need them. The investigators seek to fill this gap by developing and testing Pain Disengagement Training (PDT) for the treatment of chronic pain catastrophizing, a key risk factor for pain interference. The investigators will administer the PDT treatment in a small number (approximately 10) of participants to evaluate initial benchmarks (the feasibility of recruitment, acceptability of the treatment, credibility and participant satisfaction, treatment adherence, and feasibility of assessments) and to assess participants' experience with the intervention using qualitative exit interviews. Results will inform the refinement of the intervention for a future larger trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention involves approximately 8 sessions. The first session will involve a psychoeducation component describing the association between negative emotions and pain and the rationale for the intervention strategies. The intervention sessions will consist of approximately 30 minutes of writing alternating between imaginal exposure writing and positive writing periods alternating back and forth (e.g., 3-5 minutes of imaginal exposure writing followed by 3-5 minutes of positive writing before returning to imaginal exposure writing, etc.). Exposure writing will involve writing about a pain-related catastrophic worry repeatedly until it becomes less anxiety-provoking. The positive writing topics will change with each prompt and will be structured by session theme (e.g., values/goals, meaningful activities). They will also complete between session practice by setting aside a time for worrying and then completing a meaningful activity.
Time frame: Baseline, post-test (6 weeks)
>70% participants approached agree to participate in the intervention
Time frame: Baseline, post-test (6 weeks)
>70% of participants attend at least 6 out of 8 sessions
Time frame: Baseline
Measures perception that the treatment is credible and will offer improvements. Credibility (4 items) is rated from 1-9 with higher scores indicating more credibility. Expectancy is rated from 0-10 with higher scores indicating greater expectancy of improvement.
Time frame: Post-test (6 weeks)
Measure of client satisfaction with a program or intervention. 8-item scale measured from 1 to 4 with greater scores indicating greater satisfaction.
Time frame: Mid-intervention
Percent of writing sections demonstrate correct themes (e.g., anxiety words in imaginal exposure writing)
Time frame: Baseline, post-test (6 weeks)
>70% of participants have no measures fully missing
Time frame: Baseline, post-test (6 weeks)
Rating of pain intensity on a 0-10 1-item scale with greater scores indicating greater pain intensity
Time frame: Baseline, post-test (6 weeks)
Measure of pain severity. 3-item scale rated from 0 to 10 with greater scores indicating greater pain severity and interference
Time frame: Baseline, post-test (6 weeks)
Assesses pain interference in the past 7 days in activities, work, chores, etc. 8-item scale (1 - not at all to 5 - very much) with greater scores indicating greater pain interference.
Time frame: Baseline, post-test (6 weeks)
Assesses pain intensity (4 items) on a 0 to 10 scale with greater scores indicating worse pain intensity and interference.
Time frame: Baseline, post-test (6 weeks)
Measure of depressive symptoms. 9-item scale rated from 0 to 3 with greater scores indicating greater depressive symptoms.
Time frame: Baseline, post-test (6 weeks)
Measure of depressive symptoms. 8-item scale rated from 1 to 5 with greater scores indicating greater depressive symptoms.
Time frame: Baseline, post-test (6 weeks)
8-item measure of worry rated from 1 to 5 with greater scores indicating greater worry.
Time frame: Baseline, post-test (6 weeks)
Assesses magnification, helplessness, and rumination in response to pain. 13-item scale rated 0 to 4 with greater scores indicating greater pain catastrophizing.
Time frame: Baseline, post-test (6 weeks)
Assesses fear and anxiety in response to pain. 20-item scale rated 0 to 5 with greater scores indicating greater pain anxiety.
Time frame: Baseline, post-test (6 weeks)
Measures ability to shift attention from worry. 4-item scale rated from 0 to 10 with greater scores indicating greater ability to shift attention away from worry.
Time frame: Baseline, post-test (6 weeks)
Assesses engagement in meaningful activities. 9-item measure rated from 0 to 6 with greater scores indicating greater activity engagement.
Time frame: Mid-intervention
Assesses level of emotional intensity on a 4-item scale from 1 to 5 with greater scores indicating more positive emotionality.
Time frame: Baseline, post-test (6 weeks)
Measures ability to sustain negative emotionality to protect against sudden shifts in emotion. 25-item scale rated from 1 to 5 with greater scores indicating greater avoidance of contrasting emotional states.
Time frame: Baseline, post-test (6-weeks)
4 item scale assessing meaning and fulfillment in life (1 to 5 rating scale)
Time frame: Baseline, Post-test (6 weeks)
12 item 1 to 5 scale measuring self-compassion
Contact information is provided by the study sponsor or research team.
Ana-Maria Vranceanu, PhD
CONTACT
Katherine McDermott, PhD
CONTACT
Massachusetts General Hospital
Other
Pain Disengagement Training: A Self-directed Intervention for Pain Catastrophizing (Open Pilot)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07732062
Cannabis Use, Chronic Musculoskeletal Pain
Tel Aviv, Israel
View Trial DetailsNCT07001449
Chronic Musculoskeletal Pain
Lamia, Central Greece, Greece
View Trial DetailsNCT05701982
Behavior, COPD
Boston, Massachusetts, United States
View Trial DetailsNCT07347028
Brain Diseases, Central Nervous System Diseases
Beijing, Beijing Municipality, China
View Trial Details